![Ken Takeshita](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Takeshita
No open positions remaining
Career history of Ken Takeshita
Former positions of Ken Takeshita
| Companies | Position | Start | End |
|---|---|---|---|
| KITE PHARMA INC | Chief Tech/Sci/R&D Officer | - | 09/02/2021 |
| DAIICHI SANKYO COMPANY, LIMITED | Chief Tech/Sci/R&D Officer | 01/04/2021 | - |
Statistics
International
| United States | 2 |
| Japan | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DAIICHI SANKYO COMPANY, LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on June 1, 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Ken Takeshita
- Experience
